HighMark Wealth Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19K | Buy |
171
+1
| +0.6% | +$111 | 0.01% | 229 |
|
|
2025
Q1 | $19.1K | Sell |
170
-10
| -6% | -$1.12K | 0.01% | 202 |
|
|
2024
Q4 | $16.6K | Buy |
180
+62
| +53% | +$5.73K | 0.01% | 222 |
|
|
2024
Q3 | $9.91K | Buy |
118
+1
| +0.9% | +$84 | 0.01% | 302 |
|
|
2024
Q2 | $8.04K | Buy |
117
+1
| +0.9% | +$69 | ﹤0.01% | 321 |
|
|
2024
Q1 | $10.9K | Buy |
116
+1
| +0.9% | +$94 | 0.01% | 263 |
|
|
2023
Q4 | $9.29K | Buy |
115
+1
| +0.9% | +$81 | 0.01% | 274 |
|
|
2023
Q3 | $8.51K | Buy |
114
+2
| +2% | +$149 | 0.01% | 276 |
|
|
2023
Q2 | $8.67K | Buy |
112
+1
| +0.9% | +$77 | 0.01% | 277 |
|
|
2023
Q1 | $9.24K | Buy |
111
+1
| +0.9% | +$83 | 0.01% | 308 |
|
|
2022
Q4 | $9.47K | Buy |
110
+1
| +0.9% | +$86 | 0.01% | 265 |
|
|
2022
Q3 | $7K | Buy |
109
+1
| +0.9% | +$64 | 0.01% | 287 |
|
|
2022
Q2 | $7K | Buy |
108
+1
| +0.9% | +$65 | 0.01% | 297 |
|
|
2022
Q1 | $6K | Buy |
107
+1
| +0.9% | +$56 | ﹤0.01% | 336 |
|
|
2021
Q4 | $8K | Buy |
106
+1
| +1% | +$75 | 0.01% | 292 |
|
|
2021
Q3 | $7K | Buy |
105
+1
| +1% | +$67 | 0.01% | 300 |
|
|
2021
Q2 | $7K | Buy |
104
+2
| +2% | +$135 | 0.01% | 305 |
|
|
2021
Q1 | $7K | Buy |
102
+1
| +1% | +$69 | 0.01% | 294 |
|
|
2020
Q4 | $6K | Buy |
101
+1
| +1% | +$59 | 0.01% | 302 |
|
|
2020
Q3 | $6K | Buy |
100
+1
| +1% | +$60 | 0.01% | 294 |
|
|
2020
Q2 | $8K | Buy |
99
+1
| +1% | +$81 | 0.01% | 237 |
|
|
2020
Q1 | $7K | Sell |
98
-220
| -69% | -$15.7K | 0.01% | 183 |
|
|
2019
Q4 | $20K | Buy |
+318
| New | +$20K | 0.02% | 129 |
|